Adapttech secures £2.3m Series A funding from Mercia Asset Management and others to develop wearable technologies.
The biomedical startup has closed a £2.3m Series A round backed by Mercia Asset Management, ACF Investors, Wren Capital and Wealth Club.
Adapttech is a biomedical enterprise that creates wearable technologies to assist individuals with physical limitations. Its flagship offering combines 3D scanning with dynamic pressure data to streamline prosthetic fitting.
Adapttech has secured £2.3m in a Series A funding round to advance its wearable technology portfolio. The investment was backed by Mercia Asset Management, ACF Investors, Wren Capital and Wealth Club.
The capital will be directed towards the ongoing development of smart technologies designed to enhance the lives of people with physical impairments. This announcement coincides with the rollout of the company's new INSIGHT product range, aimed at improving fitting processes for lower-limb prostheses.
Investor perspective
"Adapttech brought its first product to market during 2021, successfully securing a number of sales. We are delighted to be supporting the team with a follow-on investment to continue to scale the business and build out the product portfolio."
Stephen Windsor
Investment Director, Mercia Asset Management
Use of funds
- 01Continue product development
